- Home>
- Specialty Care>
- Oncology and Hematology>
- About>
- About Our Editorial Board
About the Journal Watch Oncology and Hematology Editorial Board
William J. Gradishar, MD, Editor-in-Chief
William J. Gradishar, MD, is Professor of Medicine and Director of Breast Medical Oncology at the Robert H. Lurie Comprehensive Cancer Center at Northwestern Feinberg School of Medicine in Chicago, IL.
Robert Dreicer, MD, MS, FACP, Associate Editor
Robert Dreicer, MD, MS, FACP, is Chair of the Department of Solid Tumor Oncology at the Taussig Cancer Center at the Cleveland Clinic. In addition, he is Professor of Medicine at the Cleveland Clinic Lerner College of Medicine in Cleveland, OH.
David Green, MD, PhD, Associate Editor
David Green, MD, PhD, is Professor of Medicine in the Division of Hematology/Oncology at Northwestern University Feinberg School of Medicine in Chicago, IL.
David H. Ilson, MD, PhD, Associate Editor
David H. Ilson, MD, PhD, is Associate Attending Physician at Memorial Sloan-Kettering Cancer Center and Associate Professor at Cornell University Medical College, New York.
Henry Mark Kuerer, MD, PhD, FACS, Associate Editor
Henry Mark Kuerer, MD, PhD, FACS, is Professor of Surgery and Director of the Breast Surgical Oncology Training Program at the University of Texas M.D. Anderson Cancer Research Center in Houston, TX.
Barbara A. Murphy, MD, Associate Editor
Barbara A. Murphy, MD, is Associate Professor of Medicine in the Division of Hematology/Oncology and Director of the Pain and Symptom Management Program at Vanderbilt University, Nashville, TN.
Michael E. Williams, MD, Associate Editor
Michael E. Williams, MD, is the Byrd S. Leavell Professor of Medicine and Director of the Hematologic Malignancy Program at the University of Virginia School of Medicine in Charlottesville, VA.
EDITORS WHO HAVE LEFT THE BOARD SINCE JANUARY 2007
Manuel Hidalgo, MD, PhD, Associate Editor 2006-2008
Dr. Hidalgo is an Associate Professor of Oncology and Co-Director of the Drug Development Program at Johns Hopkins University School of Medicine. He received his medical degree from the University Navarra Medical School in Pamplona, Spain, and his doctorate degree from the University of Autonoma in Madrid, Spain. In 1997, he began his career as a clinical research fellow at the Cancer Therapy and Research Center in San Antonio, Texas, where he participated in the EORTC/NCI Exchange Fellowship and AACR Young Investigator Fellowship in Clinical Research. He worked as both an Assistant Professor of Medicine at the University of Texas Health Science Center and as a clinical investigator at the Cancer Therapy and Research Center. He received an ASCO Career Development Award in 2001. Dr. Hidalgo wrote for Journal Watch Oncology and Hematology from its inception in 2006 through 2008.
Mark A. Socinski, MD, Associate Editor 2006–2007
Dr. Socinski serves as the Director of the Multidisciplinary Thoracic Oncology Program at the University of North Carolina and Lineberger Comprehensive Cancer Center (LCCC). His primary research involves clinical trials in both non-small cell (NSCLC) as well as small cell lung cancer (SCLC). He is the Principal Investigator for several national and investigator-initiated LCCC trials on the optimal chemotherapeutic approach to advanced, metastatic NSCLC. Dr. Socinski serves as chair of a national trial of novel chemotherapeutic approaches in stage I and II NSCLC as pre-operative therapy. He is currently involved with the American College of Chest Physicians Lung Cancer Guidelines Committee and serves on the Advisory Board of Lungcancer.org. He wrote for Journal Watch Oncology and Hematology from its inception in 2006 through 2007.